Results 1 to 10 of about 460,428 (364)

FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report [PDF]

Cancer Reports, 2023
Background T‐lymphoblastic lymphoma (T‐LBL) is an aggressive malignancy of T‐lymphoid precursors, rarely co‐occurring with myeloid/lymphoid neoplasms with eosinophilia (M/LNs‐Eo), with consequent rearrangement of tyrosine kinase (TK)‐related genes.
Salhah Ali, Yasmine Al‐Qattan, Walaa Awny, Abdulaziz Hamadah, Karen Pinto, Salem AlShemmari   +5 more
doaj   +2 more sources

Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia [PDF]

Case Reports in Hematology, 2023
Mixed phenotype acute leukemia (MPAL) is characterized by leukemic blasts that express markers of multiple lineages. Compared with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), MPAL is considered to have a poor treatment outcome ...
Mako Ikeda, Wataru Nakahara, Mizuki Asako, Yuka Umeki, Yoshiki Matsuoka, Takuya Terakawa, Hitomi Matsunaga, Yuki Iwasa, Riko Saito, Yuki Iwama, Takahiro Matsui, Kazumasa Oka, Shuji Ueda   +12 more
doaj   +2 more sources

Sellar B lymphoblastic lymphoma mimics pituitary apoplexy with newly discovered gene mutations in TP53 and PAX5: A case report

Frontiers in Oncology, 2023
Lymphoblastic lymphoma (LBL) is a rare tumor that accounts for approximately 2-4% of all non-Hodgkin lymphomas, and less than 20% of LBLs are derived from B cells.
Yi Wang, Yajun Yang, Qiuxia Wang, Ce Wang, Xinjuan Xu, Dongao Wang, Feirong Bai, Panpan Li, Xintao Huang   +8 more
doaj   +1 more source

Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases

Case Reports in Hematology, 2022
Treatment of early relapses of T lymphoblastic leukemia/lymphoma is often unsuccessful. We tested an experimental regimen containing daratumumab and nelarabine in two young patients with early relapses of T lymphoblastic lymphoma and T-ALL, respectively.
Ingolf Molle, Irma Petruskevicius, Peter Kamper, Francesco d’Amore   +3 more
doaj   +1 more source

The chemotherapy of lymphoblastic lymphoma [PDF]

Blood, 1981
Abstract Thirty-two patients treated on consecutive Southwest Oncology Group (SWOG) protocols for malignant lymphoma were subsequently diagnosed as having lymphoblastic lymphoma. Combination chemistry, usually adriamycin-based, produced complete responses (CR) in 17 patients (53%). Median survival was 15 mo.
Eugene M. McKelvey, Eugene M. McKelvey, Stephen E. Jones, Stephen E. Jones, Jane B. Voakes, Jane B. Voakes   +5 more
openaire   +4 more sources

Extranodal Biphenotypic Non-Hodgkin Lymphoma of the Popliteal Cavity: A Case Report and Review of Literature

Diagnostics, 2022
Primary soft-tissue lymphoma (PSTL) is a rare extranodal non-Hodgkin lymphoma, characterized by a mass growing within soft-tissue, which is connective tissue, adipose tissue, and skeletal muscle.
Giulia A. Restivo, Lara Mussolin, Paolo D’Angelo, Angelica Zin, Martina Pigazzi, Elisa Carraro, Emanuele S. G. D’Amore, Marta Pillon, Piero Farruggia   +8 more
doaj   +1 more source

Lymphoblastic lymphoma in adults [PDF]

Cancer, 1981
Clinical and cytogenetic studied were done on 12 patients with lymphoblastic lymphoma. The ages of the patients ranged from 17 to 58 years (median, 24.5 years). Males predominated by a ration of 5:1. Ten of the 12 patients had a mediastinal mass at diagnosis; two thirds of the patients had involvement of the bone marrow (3 of 12 patients initially were
Yasuhiko Kaneko, Daina Variakojis, Janet D. Rowley, Harvey M. Golomb, Rolf A. Streuli, Ann Kinnealey   +5 more
openaire   +3 more sources

Lymphoblastic lymphoma in two young siblings (coincidence or genetics?): two case reports

Journal of Medical Case Reports, 2021
Background Non-Hodgkin lymphoma is the fourth most common malignancy in children, and it is not considered to be a hereditary disorder. However, it could affect members from the same family.
Naya Talal Hassan, Ebrahim Makhoul, Jafar Sallameh, Abdulmunem Ghanem, Samer Rajab, Waseem Ali, Zuheir Alshehabi   +6 more
doaj   +1 more source

T-Lymphoblastic Leukemia/Lymphoma [PDF]

American Journal of Clinical Pathology, 2015
To review important concepts from the 2013 Society for Hematopathology/European Association for Haematopathology Workshop session on T-acute lymphoblastic leukemia/T-lymphoblastic lymphoma (T-ALL/T-LBL).Twenty-one submitted cases are reviewed and summarized, with emphasis on key diagnostic or biologic points, and supplemented with relevant literature ...
L. Jeffrey Medeiros, M. James You, Eric D. Hsi   +2 more
openaire   +3 more sources

Malignant lymphoma, lymphoblastic [PDF]

Cancer, 1976
Among the malignant lymphomas of the diffuse, poorly differentiated lymphocytic type, a cytologically distinctive form can be recognized. It is composed of immature lymphoid cells that are indistinguishable from the cells of acute lymphoblastic leukemia (ALL).
Hun Kim, Bharat N. Nathwani, Henry Rappaport   +2 more
openaire   +2 more sources